PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26152132-0	2015	Bioequivalence of different dose-strength tablets of selexipag, a selective prostacyclin receptor agonist, in a multiple-dose up-titration study.	selexipag	53-62	prostaglandin I2 receptor	Homo sapiens	76-97	
26152132-1	2015	OBJECTIVE: Selexipag is a novel, oral, selective prostacyclin (PGI2) receptor agonist in clinical development for the treatment of pulmonary arterial hypertension.	selexipag	11-20	prostaglandin I2 receptor	Homo sapiens	63-77